Recruiting
CD19/CD22 CAR-T Consolidation in R/R Aggressive B-Cell Lymphoma After Second-Line Therapy
NCT07779018
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- Chinese PLA General Hospital, Beijing, Beijing 100853 Beijing, China